Graves’ Disease: Pathogenesis and Treatment
From the perspective of the investigator, Graves' disease is a fascinating disorder with unique features and opportunities for study. The discovery in 1956 that Graves' disease was caused by a humoral factor, later shown to be an antibody to the TSH receptor, was a triumph for modern inves...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Boston, MA
Springer US
2000
|
Schriftenreihe: | Endocrine Updates
6 |
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | From the perspective of the investigator, Graves' disease is a fascinating disorder with unique features and opportunities for study. The discovery in 1956 that Graves' disease was caused by a humoral factor, later shown to be an antibody to the TSH receptor, was a triumph for modern investigative medicine. Rapid progress is now being made in (i) understanding the molecular interaction between autoantibodies and the TSH receptor, (ii) identifying the genes that contribute to the predisposition to disease, (iii) developing an animal model of Graves' disease, and (iv) identifying the long-sought orbital antigen in ophthalmopathy. From the clinical standpoint, although Graves' disease is eminently treatable, there is no definitive cure. None of the therapeutic options are ideal. It is hoped that rapid progress in understanding the pathogenesis of the disease will lead to the ultimate goal of some form of immunotherapy that will make antithyroid drugs, radioiodine and thyroidectomy obsolete. The chapters in Graves' Disease: Pathogenesis and Treatment represent the viewpoints of many prominent clinicians and investigators working in the field. The editors are grateful for their contributions which cover an unusually comprehensive compendium of subjects relating to the disease |
Beschreibung: | 1 Online-Ressource (XIII, 307 p) |
ISBN: | 9781461544074 |
DOI: | 10.1007/978-1-4615-4407-4 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV046146555 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2000 |||| o||u| ||||||eng d | ||
020 | |a 9781461544074 |9 978-1-4615-4407-4 | ||
024 | 7 | |a 10.1007/978-1-4615-4407-4 |2 doi | |
035 | |a (ZDB-2-SME)978-1-4615-4407-4 | ||
035 | |a (OCoLC)1118990961 | ||
035 | |a (DE-599)BVBBV046146555 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.46 |2 23 | |
082 | 0 | |a 616.462 |2 23 | |
084 | |a YO 3647 |0 (DE-625)153942:12954 |2 rvk | ||
245 | 1 | 0 | |a Graves’ Disease |b Pathogenesis and Treatment |c edited by Basil Rapoport, Sandra M. McLachlan |
264 | 1 | |a Boston, MA |b Springer US |c 2000 | |
300 | |a 1 Online-Ressource (XIII, 307 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Endocrine Updates |v 6 | |
520 | |a From the perspective of the investigator, Graves' disease is a fascinating disorder with unique features and opportunities for study. The discovery in 1956 that Graves' disease was caused by a humoral factor, later shown to be an antibody to the TSH receptor, was a triumph for modern investigative medicine. Rapid progress is now being made in (i) understanding the molecular interaction between autoantibodies and the TSH receptor, (ii) identifying the genes that contribute to the predisposition to disease, (iii) developing an animal model of Graves' disease, and (iv) identifying the long-sought orbital antigen in ophthalmopathy. From the clinical standpoint, although Graves' disease is eminently treatable, there is no definitive cure. None of the therapeutic options are ideal. It is hoped that rapid progress in understanding the pathogenesis of the disease will lead to the ultimate goal of some form of immunotherapy that will make antithyroid drugs, radioiodine and thyroidectomy obsolete. The chapters in Graves' Disease: Pathogenesis and Treatment represent the viewpoints of many prominent clinicians and investigators working in the field. The editors are grateful for their contributions which cover an unusually comprehensive compendium of subjects relating to the disease | ||
650 | 4 | |a Diabetes | |
650 | 4 | |a Immunology | |
650 | 4 | |a Ophthalmology | |
650 | 4 | |a Diabetes | |
650 | 4 | |a Immunology | |
650 | 4 | |a Ophthalmology | |
650 | 0 | 7 | |a Basedow-Krankheit |0 (DE-588)4144092-4 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Basedow-Krankheit |0 (DE-588)4144092-4 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Rapoport, Basil |4 edt | |
700 | 1 | |a McLachlan, Sandra M. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792377900 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461369837 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461544081 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-4407-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031526740 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1007/978-1-4615-4407-4 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180484685561856 |
---|---|
any_adam_object | |
author2 | Rapoport, Basil McLachlan, Sandra M. |
author2_role | edt edt |
author2_variant | b r br s m m sm smm |
author_facet | Rapoport, Basil McLachlan, Sandra M. |
building | Verbundindex |
bvnumber | BV046146555 |
classification_rvk | YO 3647 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-4615-4407-4 (OCoLC)1118990961 (DE-599)BVBBV046146555 |
dewey-full | 616.46 616.462 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.46 616.462 |
dewey-search | 616.46 616.462 |
dewey-sort | 3616.46 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-4615-4407-4 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03228nmm a2200553zcb4500</leader><controlfield tag="001">BV046146555</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461544074</subfield><subfield code="9">978-1-4615-4407-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-4407-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4615-4407-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118990961</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146555</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.46</subfield><subfield code="2">23</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.462</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YO 3647</subfield><subfield code="0">(DE-625)153942:12954</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Graves’ Disease</subfield><subfield code="b">Pathogenesis and Treatment</subfield><subfield code="c">edited by Basil Rapoport, Sandra M. McLachlan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIII, 307 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Endocrine Updates</subfield><subfield code="v">6</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">From the perspective of the investigator, Graves' disease is a fascinating disorder with unique features and opportunities for study. The discovery in 1956 that Graves' disease was caused by a humoral factor, later shown to be an antibody to the TSH receptor, was a triumph for modern investigative medicine. Rapid progress is now being made in (i) understanding the molecular interaction between autoantibodies and the TSH receptor, (ii) identifying the genes that contribute to the predisposition to disease, (iii) developing an animal model of Graves' disease, and (iv) identifying the long-sought orbital antigen in ophthalmopathy. From the clinical standpoint, although Graves' disease is eminently treatable, there is no definitive cure. None of the therapeutic options are ideal. It is hoped that rapid progress in understanding the pathogenesis of the disease will lead to the ultimate goal of some form of immunotherapy that will make antithyroid drugs, radioiodine and thyroidectomy obsolete. The chapters in Graves' Disease: Pathogenesis and Treatment represent the viewpoints of many prominent clinicians and investigators working in the field. The editors are grateful for their contributions which cover an unusually comprehensive compendium of subjects relating to the disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Basedow-Krankheit</subfield><subfield code="0">(DE-588)4144092-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Basedow-Krankheit</subfield><subfield code="0">(DE-588)4144092-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rapoport, Basil</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McLachlan, Sandra M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792377900</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461369837</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461544081</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-4407-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526740</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-4407-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046146555 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:30Z |
institution | BVB |
isbn | 9781461544074 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526740 |
oclc_num | 1118990961 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XIII, 307 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | Springer US |
record_format | marc |
series2 | Endocrine Updates |
spelling | Graves’ Disease Pathogenesis and Treatment edited by Basil Rapoport, Sandra M. McLachlan Boston, MA Springer US 2000 1 Online-Ressource (XIII, 307 p) txt rdacontent c rdamedia cr rdacarrier Endocrine Updates 6 From the perspective of the investigator, Graves' disease is a fascinating disorder with unique features and opportunities for study. The discovery in 1956 that Graves' disease was caused by a humoral factor, later shown to be an antibody to the TSH receptor, was a triumph for modern investigative medicine. Rapid progress is now being made in (i) understanding the molecular interaction between autoantibodies and the TSH receptor, (ii) identifying the genes that contribute to the predisposition to disease, (iii) developing an animal model of Graves' disease, and (iv) identifying the long-sought orbital antigen in ophthalmopathy. From the clinical standpoint, although Graves' disease is eminently treatable, there is no definitive cure. None of the therapeutic options are ideal. It is hoped that rapid progress in understanding the pathogenesis of the disease will lead to the ultimate goal of some form of immunotherapy that will make antithyroid drugs, radioiodine and thyroidectomy obsolete. The chapters in Graves' Disease: Pathogenesis and Treatment represent the viewpoints of many prominent clinicians and investigators working in the field. The editors are grateful for their contributions which cover an unusually comprehensive compendium of subjects relating to the disease Diabetes Immunology Ophthalmology Basedow-Krankheit (DE-588)4144092-4 gnd rswk-swf Basedow-Krankheit (DE-588)4144092-4 s 1\p DE-604 Rapoport, Basil edt McLachlan, Sandra M. edt Erscheint auch als Druck-Ausgabe 9780792377900 Erscheint auch als Druck-Ausgabe 9781461369837 Erscheint auch als Druck-Ausgabe 9781461544081 https://doi.org/10.1007/978-1-4615-4407-4 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Graves’ Disease Pathogenesis and Treatment Diabetes Immunology Ophthalmology Basedow-Krankheit (DE-588)4144092-4 gnd |
subject_GND | (DE-588)4144092-4 |
title | Graves’ Disease Pathogenesis and Treatment |
title_auth | Graves’ Disease Pathogenesis and Treatment |
title_exact_search | Graves’ Disease Pathogenesis and Treatment |
title_full | Graves’ Disease Pathogenesis and Treatment edited by Basil Rapoport, Sandra M. McLachlan |
title_fullStr | Graves’ Disease Pathogenesis and Treatment edited by Basil Rapoport, Sandra M. McLachlan |
title_full_unstemmed | Graves’ Disease Pathogenesis and Treatment edited by Basil Rapoport, Sandra M. McLachlan |
title_short | Graves’ Disease |
title_sort | graves disease pathogenesis and treatment |
title_sub | Pathogenesis and Treatment |
topic | Diabetes Immunology Ophthalmology Basedow-Krankheit (DE-588)4144092-4 gnd |
topic_facet | Diabetes Immunology Ophthalmology Basedow-Krankheit |
url | https://doi.org/10.1007/978-1-4615-4407-4 |
work_keys_str_mv | AT rapoportbasil gravesdiseasepathogenesisandtreatment AT mclachlansandram gravesdiseasepathogenesisandtreatment |